DaVita Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11,764
12,795
13,782
10,707
10,877
11,405
Cost of Goods Sold (COGS) incl. D&A
8,727
9,710
10,463
7,941
8,197
8,776
Gross Income
3,037
3,085
3,319
2,766
2,680
2,629
SG&A Expense
1,181
1,276
1,461
1,085
1,057
1,128
EBIT
1,856
1,809
1,858
-
1,623
1,501
Unusual Expense
356
21
754
43
192
27
Non Operating Income/Expense
42
24
14
386
16
57
Interest Expense
451
525
413
418
422
479
Pretax Income
1,125
1,310
723
1,623
1,400
1,048
Income Tax
381
446
296
432
324
258
Consolidated Net Income
744
863
427
1,191
1,076
790
Net Income
620
723
270
1,032
901
624
Net Income After Extraordinaries
607
723
270
1,185
1,139
1,089
Net Income Available to Common
620
723
270
880
664
159
EPS (Basic)
2.95
3.33
1.25
4.29
3.47
0.92
Basic Shares Outstanding
210
212
212
202
189
171
EPS (Diluted)
2.95
3.33
1.25
4.29
3.47
0.92
Diluted Shares Outstanding
215
217
216
205
191
172
EBITDA
2,384
2,400
2,496
2,191
2,183
2,092
Minority Interest Expense
124
140
158
159
175
166
Equity in Affiliates (Pretax)
35
23
18
17
9
4

About DaVita

View Profile
Address
2000 16th Street
Denver Colorado 80202
United States
Employees -
Website http://www.davita.com
Updated 07/08/2019
DaVita, Inc. engages in the provision of medical care services. It operates through the following US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.